Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Potential Interaction of Proton Pump Inhibitors with Clopidogrel-containing medicines (Plavix) - Important Safety Information from sanofi-aventis Ireland Ltd. as approved by the Irish Medicines Board
Notice type:
3rd Party Publications
Date:
05/08/2009
Problem Or Issue:
Important safety information communication from sanofi-aventis and Bristol-Myers Squibb on the potential interaction of Proton Pump Inhibitors with Clopidogrel-containing medicines (Plavix®).
Important Safety Information - Proton Pump Inhibitors and Clopidogrel-containing medicines (Plavix)
Plavix 75 mg - updated SPC
« Back
Date Printed: 04/05/2024